Phosphatase-degradable nanoparticles: A game-changing approach for the delivery of antifungal proteins

• Published in: Journal of colloid and interface science Vol. 646; pp. 290 - 300
• Main Authors: Akkuş-Dağdeviren, Zeynep Burcu, Saleh, Ahmad, Schöpf, Cristina, Truszkowska, Martyna, Bratschun-Khan, Doris, Fürst, Andrea, Seybold, Anna, Offterdinger, Martin, Marx, Florentine, Bernkop-Schnürch, Andreas
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 15.09.2023
• Subjects: Antifungal protein; Biofilm; Candida albicans; Enzyme-responsive nanocarriers; Phosphatase; Polymeric nanoparticles; Polyphosphate; Candida albicans; Polyphosphate; Polymeric nanoparticles; Biofilm; Enzyme-responsive nanocarriers; Phosphatase; Antifungal protein
• ISSN: 0021-9797; 1095-7103
• DOI: 10.1016/j.jcis.2023.05.051

[Display omitted] Polyphosphate nanoparticles as phosphatase-degradable carriers for Penicillium chrysogenum antifungal protein (PAF) can enhance the antifungal activity of the protein against Candida albicans biofilm. PAF-polyphosphate (PP) nanoparticles (PAF-PP NPs) were obtained through ionic gelation. The resulting NPs were characterized in terms of their particle size, size distribution and zeta potential. Cell viability and hemolysis studies were carried out in vitro on human foreskin fibroblasts (Hs 68 cells) and human erythrocytes, respectively. Enzymatic degradation of NPs was investigated by monitoring release of free monophosphates in the presence of isolated as well as C. albicans-derived phosphatases. In parallel, shift in zeta potential of PAF-PP NPs as a response to phosphatase stimuli was determined. Diffusion of PAF and PAF-PP NPs through C. albicans biofilm matrix was analysed by fluorescence correlation spectroscopy (FCS). Antifungal synergy was evaluated on C. albicans biofilm by determining the colony forming units (CFU). PAF-PP NPs were obtained with a mean size of 300.9 ± 4.6 nm and a zeta potential of −11.2 ± 2.8 mV. In vitro toxicity assessments revealed that PAF-PP NPs were highly tolerable by Hs 68 cells and human erythrocytes similar to PAF. Within 24 h, 21.9 ± 0.4 μM of monophosphate was released upon incubation of PAF-PP NPs having final PAF concentration of 156 μg/ml with isolated phosphatase (2 U/ml) leading to a shift in zeta potential up to −0.7 ± 0.3 mV. This monophosphate release from PAF-PP NPs was also observed in the presence of C. albicans-derived extracellular phosphatases. The diffusivity of PAF-PP NPs within 48 h old C. albicans biofilm matrix was similar to that of PAF. PAF-PP NPs enhanced antifungal activity of PAF against C. albicans biofilm decreasing the survival of the pathogen up to 7-fold in comparison to naked PAF. In conclusion, phosphatase-degradable PAF-PP NPs hold promise as nanocarriers to augment the antifungal activity of PAF and enable its efficient delivery to C. albicans cells for the potential treatment of Candida infections.